Stockscreener 앱 받기
15.22
0.85%
-0.13
시간 외 거래:
15.26
0.04
+0.26%
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a shareEarnings Preview - TradingView
Aurinia Pharmaceuticals Inc (AUPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aurinia Pharmaceuticals Inc. Revenue Breakdown – LS:A1W7D4 - TradingView
AUPH|Aurinia Pharmaceuticals Inc|Price:15.350|Chg%:+0.110 - TradingKey
AUPH|Aurinia Pharmaceuticals Inc|Price:15.400|Chg%:+0.160 - TradingKey
TradingKey - TradingKey
AUPH Q2'26 Earnings: revenue estimate is 80.45M USD - TradingView
Liquidity Mapping Around (AUPH) Price Events - Stock Traders Daily
Aurinia Pharmaceuticals Inc (AUPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aurinia Pharmaceuticals Inc (AUPH) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Aurinia Pharmaceuticals Inc (AUPH) Fundamental & Financial Data - Stocktwits
Aurinia Pharmaceuticals (AUPH) Q1 2026 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Proxy filing Summary - Quartr
Aurinia Pharmaceuticals (AUPH) Proxy Filing Summary - Quartr
Aurinia Pharmaceuticals (AUPH) 2024 Cantor Fitzgerald Global Healthcare Conference summary - Quartr
Aurinia Pharmaceuticals (AUPH) Q4 2024 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Q4 2025 earnings summary - Quartr
Aurinia Pharmaceuticals (AUPH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Investors - Aurinia Pharmaceuticals Inc.
AUPH Stock Sees Biggest Single-Day Drop In More Than 9 Months Despite Q1 Earnings Beat – Here’s What’s Spooking Investors - Stocktwits
bullish divergence on the hourly has held above support at 15.50, i like the stock 😀 - Moomoo
Price to earnings forward of Aurinia Pharmaceuticals Inc. – SWB:IKAP - TradingView
Is Aurinia Pharmaceuticals (AUPH) Using Combination LN Trials to Redefine Its LUPKYNIS Strategy? - Sahm
Price to earnings forward of Aurinia Pharmaceuticals Inc. – MUN:IKAP - TradingView
AUPH Stock Price and Chart — NASDAQ:AUPH - TradingView
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis - BioSpace
TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Aurinia Unchanged on Unveiling Lupus Treatment - Baystreet.ca
Aurinia launches trial combining lupus nephritis treatments - Investing.com
Aurinia Pharmaceuticals Initiates Phase 4 PRESERVE Study in Lupus Nephritis Combination Therapy - Moomoo
Aurinia launches trial combining lupus nephritis treatments By Investing.com - Investing.com South Africa
Aurinia Pharmaceuticals balances autoimmune drug focus and U.S. market ambitions - Ad-hoc-news.de
Enterprise value to EBITDA forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
AUPHAurinia Pharmaceuticals Inc Latest SEC Filings - Finviz
Document - SEC.gov
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why - Yahoo Finance
If EPS Growth Is Important To You, Aurinia Pharmaceuticals (NASDAQ:AUPH) Presents An Opportunity - Moomoo
Why (AUPH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now? - Insider Monkey
IKAP Forecast — Price Target — Prediction for 2027 - TradingView
Aurinia Pharmaceuticals Inc (AUPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to sales forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Aurinia Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:AUPH) - TradingView
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Enterprise value to EBIT forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Price to earnings forward of Aurinia Pharmaceuticals Inc. – LSX:A1W7D4 - TradingView
Aurinia Pharmaceuticals Inc. Actuals & Estimates (SWB:IKAP) - TradingView
AUPH Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Price to book forward of Aurinia Pharmaceuticals Inc – NASDAQ:AUPH - TradingView
Enterprise value to EBITDA forward of Aurinia Pharmaceuticals Inc. – LSX:A1W7D4 - TradingView
Price to sales forward of Aurinia Pharmaceuticals Inc. – LSX:A1W7D4 - TradingView
1.97%
0.83%
자본화:
|
볼륨(24시간):